Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01100723 · ClinicalTrials.gov registry record · Phase 4
Trial to Optimize Mineral Outcomes in Dialysis Patients
A Phase 4 study of Chronic Kidney Disease and Secondary Hyperparathyroidism, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- Phase 4
- Development phase
- 92
- Enrollment target
- 1
- Study location
NCT01100723 is a Phase 4 study of Chronic Kidney Disease and Secondary Hyperparathyroidism that has completed, run by University of Colorado, Denver. The registered enrollment target is 92 participants, below the 3,206-participant average among 101 other Chronic Kidney Disease trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01100723, a Phase 4 study of Chronic Kidney Disease and Secondary Hyperparathyroidism, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 92 participants
- Enrollment target
- 1
- Study location
Study Summary
This trial is designed to determine if the use of a computer algorithm designed to optimize mineral outcomes in dialysis patients increases the number of patients achieving the desired target endpoints for calcium, phosphorus and parathyroid hormone.
Conditions Studied
Interventions
- OTHER Cinacalcet, active vitamin D analogue
Study Locations (1)
Virginia
- Lynchburg Nephrology Associates, P.L.L.C. - Lynchburg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 92 participants |
| Start Date | 2010-03 |
| Est. Completion | 2011-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01100723
The ClinicalTrials.gov registry entry for NCT01100723 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 92 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,206-participant average among 101 other Chronic Kidney Disease trials with a reported enrollment target (97% lower). The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Chronic Kidney Disease appearing as the primary indexed condition, and to 1 intervention - of which Cinacalcet, active vitamin D analogue is the first listed.
NCT01100723 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.
Frequently Asked Questions
What is clinical trial NCT01100723 about?
NCT01100723 is a clinical study titled "Trial to Optimize Mineral Outcomes in Dialysis Patients". This trial is designed to determine if the use of a computer algorithm designed to optimize mineral outcomes in dialysis patients increases the number of patients achieving the desired target endpoints for calcium, phosphorus and parathyroid hormone.
What is the current status of trial NCT01100723?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 92 participants. The study started on 2010-03. Estimated completion is 2011-08.
What conditions does trial NCT01100723 study?
This clinical trial studies the following conditions: Chronic Kidney Disease, Secondary Hyperparathyroidism.
What interventions are being tested in trial NCT01100723?
The interventions under investigation include: Cinacalcet, active vitamin D analogue (OTHER).
Who is sponsoring clinical trial NCT01100723?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01100723 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Kidney Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Safety of Short-course of NSAIDs in Pediatric Patients With CKD
RECRUITING · Phase 4
-
L-arginine to Reduce Sympathetic Nerve Activity in CKD Patients
RECRUITING · Phase 4
-
Empagliflozin Treatment in Kidney Transplant Recipients
RECRUITING · Phase 4
-
Phosphate Lowering in CKD Trial
COMPLETED · Phase 4
-
A Chronic Care Model Based Quality Improvement (QI) Program to Improve the Care of Patients With Chronic Kidney Disease (CKD)
COMPLETED · Phase 4
-
Dialysis Clinical Outcomes Revisited (DCOR) Trial
COMPLETED · Phase 4
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.